Stock listing
CSE:DTR DiagnosTear Technologies, Inc. Stock
Home listing (CSE) of DiagnosTear Technologies, Inc.
Follow DiagnosTear Technologies, Inc. into a list and get an email when it puts out news.
Share price · CSE:DTR
$0.26 CAD +0.01 (+4.0%)
Close on Oct 30, 2026 · Data provided by Twelve Data
- Day range
- $0.25 – $0.26 CADOct 30, 2026
- Volume
- 11,500 sharesOct 30, 2026
- 52-week range
- $0.21 – $0.88 CADLowest and highest trades, Nov 3, 2025 – Oct 30, 2026
- Traded on an average day
- $535 CADMedian day 500 shares · 30 days with no trades · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| CSE:DTR · Home | $0.26 CAD | +0.01 (+4.0%) | 11,500 | $0.25 | $0.26 | $0.25 | $0.25 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · CSE:DTR · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.26 | +0.01 | +4.0% | $0.25 | $0.26 | $0.25 | 11,500 | |
| $0.25 | 0.00 | 0.0% | $0.25 | $0.25 | $0.25 | 0 | |
| $0.25 | 0.00 | 0.0% | $0.25 | $0.25 | $0.25 | 0 | |
| $0.25 | 0.00 | 0.0% | $0.25 | $0.25 | $0.25 | 0 | |
| $0.25 | 0.00 | 0.0% | $0.25 | $0.25 | $0.25 | 500 | |
| $0.25 | +0.025 | +11.1% | $0.25 | $0.25 | $0.25 | 500 | |
| $0.225 | 0.00 | 0.0% | $0.225 | $0.225 | $0.225 | 0 | |
| $0.225 | 0.00 | 0.0% | $0.225 | $0.225 | $0.225 | 0 | |
| $0.225 | 0.00 | 0.0% | $0.225 | $0.225 | $0.225 | 0 | |
| $0.225 | -0.025 | -10.0% | $0.235 | $0.235 | $0.225 | 1,000 | |
| $0.25 | 0.00 | 0.0% | $0.25 | $0.25 | $0.25 | 500 | |
| $0.25 | 0.00 | 0.0% | $0.25 | $0.25 | $0.25 | 1,500 | |
| $0.25 | -0.04 | -13.8% | $0.275 | $0.275 | $0.25 | 7,000 | |
| $0.29 | +0.045 | +18.4% | $0.27 | $0.30 | $0.27 | 20,500 | |
| $0.245 | -0.015 | -5.8% | $0.245 | $0.245 | $0.245 | 500 | |
| $0.26 | 0.00 | 0.0% | $0.26 | $0.26 | $0.26 | 0 | |
| $0.26 | -0.01 | -3.7% | $0.26 | $0.26 | $0.26 | 500 | |
| $0.27 | 0.00 | 0.0% | $0.27 | $0.27 | $0.27 | 0 | |
| $0.27 | 0.00 | 0.0% | $0.27 | $0.27 | $0.27 | 0 | |
| $0.27 | 0.00 | 0.0% | $0.27 | $0.27 | $0.27 | 0 | |
| $0.27 | 0.00 | 0.0% | $0.27 | $0.27 | $0.27 | 0 | |
| $0.27 | 0.00 | 0.0% | $0.27 | $0.27 | $0.27 | 500 | |
| $0.27 | 0.00 | 0.0% | $0.27 | $0.27 | $0.27 | 0 | |
| $0.27 | 0.00 | 0.0% | $0.27 | $0.27 | $0.27 | 0 | |
| $0.27 | 0.00 | 0.0% | $0.27 | $0.27 | $0.27 | 500 | |
| $0.27 | 0.00 | 0.0% | $0.27 | $0.27 | $0.27 | 0 | |
| $0.27 | 0.00 | 0.0% | $0.27 | $0.27 | $0.27 | 0 | |
| $0.27 | +0.01 | +3.8% | $0.255 | $0.27 | $0.255 | 2,356 | |
| $0.26 | -0.03 | -10.3% | $0.26 | $0.26 | $0.26 | 19,230 | |
| $0.29 | 0.00 | 0.0% | $0.29 | $0.29 | $0.29 | 0 | |
| $0.29 | 0.00 | 0.0% | $0.29 | $0.29 | $0.29 | 500 | |
| $0.29 | 0.00 | 0.0% | $0.29 | $0.29 | $0.29 | 0 | |
| $0.29 | +0.005 | +1.8% | $0.29 | $0.29 | $0.29 | 500 | |
| $0.285 | -0.005 | -1.7% | $0.285 | $0.285 | $0.285 | 500 | |
| $0.29 | +0.01 | +3.6% | $0.29 | $0.29 | $0.29 | 500 | |
| $0.28 | -0.01 | -3.4% | $0.29 | $0.29 | $0.265 | 3,000 | |
| $0.29 | 0.00 | 0.0% | $0.29 | $0.29 | $0.29 | 500 | |
| $0.29 | 0.00 | 0.0% | $0.29 | $0.29 | $0.29 | 500 | |
| $0.29 | 0.00 | 0.0% | $0.29 | $0.29 | $0.29 | 500 | |
| $0.29 | 0.00 | 0.0% | $0.29 | $0.29 | $0.29 | 500 | |
| $0.29 | +0.03 | +11.5% | $0.29 | $0.29 | $0.29 | 616 | |
| $0.26 | 0.00 | 0.0% | $0.26 | $0.26 | $0.26 | 0 | |
| $0.26 | 0.00 | 0.0% | $0.26 | $0.26 | $0.26 | 0 | |
| $0.26 | 0.00 | 0.0% | $0.26 | $0.26 | $0.26 | 0 | |
| $0.26 | 0.00 | 0.0% | $0.26 | $0.26 | $0.26 | 0 | |
| $0.26 | 0.00 | 0.0% | $0.26 | $0.26 | $0.26 | 0 | |
| $0.26 | 0.00 | 0.0% | $0.26 | $0.26 | $0.26 | 500 | |
| $0.26 | -0.03 | -10.3% | $0.26 | $0.26 | $0.25 | 29,461 | |
| $0.29 | 0.00 | 0.0% | $0.29 | $0.29 | $0.29 | 0 | |
| $0.29 | 0.00 | 0.0% | $0.29 | $0.29 | $0.29 | 0 | |
| $0.29 | 0.00 | 0.0% | $0.29 | $0.29 | $0.29 | 0 | |
| $0.29 | 0.00 | 0.0% | $0.29 | $0.29 | $0.29 | 0 | |
| $0.29 | 0.00 | 0.0% | $0.29 | $0.29 | $0.29 | 500 | |
| $0.29 | -0.005 | -1.7% | $0.29 | $0.29 | $0.29 | 500 | |
| $0.295 | 0.00 | 0.0% | $0.295 | $0.295 | $0.295 | 0 | |
| $0.295 | 0.00 | 0.0% | $0.295 | $0.295 | $0.295 | 0 | |
| $0.295 | +0.005 | +1.7% | $0.295 | $0.295 | $0.295 | 500 | |
| $0.29 | +0.04 | +16.0% | $0.29 | $0.29 | $0.29 | 500 | |
| $0.25 | +0.02 | +8.7% | $0.26 | $0.26 | $0.25 | 6,000 | |
| $0.23 | -0.04 | -14.8% | $0.21 | $0.26 | $0.21 | 12,500 | |
| $0.27 | 0.00 | 0.0% | $0.29 | $0.29 | $0.27 | 5,000 | |
| $0.27 | -0.03 | -10.0% | $0.27 | $0.27 | $0.27 | 500 | |
| $0.30 | 0.00 | 0.0% | $0.30 | $0.30 | $0.30 | 0 | |
| $0.30 | 0.00 | 0.0% | $0.30 | $0.30 | $0.30 | 0 |
- Ticker
- CSE:DTR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- CSE
- Currency
- CAD
What changed lately
Latest news
DiagnosTear Announces Positive Final Results from Clinical Study Demonstrating Strong Diagnostic Performance of TeaRx(TM) Red Eye for Detecting Total Tear IgE as a Biomarker for Allergic conjunctivitis
Sep 10, 2026
Closed $0.28 (-3.4%) on Sep 10, 2026
DiagnosTear Technologies Announces FDA Pre-Submission for TeaRx(TM) Red Eye Diagnostic Test
Sep 3, 2026
Closed $0.29 (0.0%) on Sep 3, 2026
DiagnosTear Technologies Inc. Announces Private Placement of Units
Aug 31, 2026
Closed $0.26 (0.0%) on Aug 31, 2026
DiagnosTear Announces Interim Clinical Study Results Demonstrating Excellent Correlation Between TeaRx(TM) Red Eye and Quantitative ELISA Testing
Jul 9, 2026
Closed $0.31 (+3.3%) on Jul 9, 2026
DiagnosTear Achieves Major Scientific Milestone with Publication of TeaRx(TM) Clinical Study in Current Eye Research Journal
Jun 5, 2026
Closed $0.29 (-3.3%) on Jun 5, 2026
DiagnosTear Secures Exclusive Global Rights to CLARIFY Eye Imaging Platform for Needle-Free Blood Diagnostics
May 12, 2026
Closed $0.39 (+30.0%) on May 13, 2026
DiagnosTear Technologies Inc. Announces Results of AGM
May 7, 2026
Closed $0.315 (-4.5%) on May 8, 2026
DiagnosTear Technologies Inc. Announces Warrant Extension
May 4, 2026
Closed $0.325 (+12.1%) on May 4, 2026
DiagnosTear Technologies Inc. Announces Adoption of Semi-Annual Reporting
Apr 21, 2026
Closed $0.325 (0.0%) on Apr 22, 2026
DiagnosTear Announces Regulatory Approvals in France and Study Initiation with AlyaTec for TeaRx(TM) Red Eye
Feb 26, 2026
Closed $0.435 (+11.5%) on Feb 27, 2026
Financings
Private placement of units
Aug 31, 2026 · US$1.01M
Announced: up to C$1.4M · C$0.5 a unit · 1 warrant at C$1 for 12 months
Buyers: BioLight Life Sciences Ltd. (up to one-third of the total Offering); Elcam Medical Ltd. (up to one-third of the total Offering)
Insiders: Certain insiders may acquire Units; participation would be a related party transaction expected to be exempt under MI 61-101
Use of proceeds: Working capital and general corporate purposes
Decks
Investor Presentation (January 2025)
Investor deck · 17 slides · January 2025
DiagnosTear Technologies, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 18 in the last 12 months · 22 in all · newest Sep 10, 2026 · oldest 2024
- Decks
- 1 deck · latest January 2025
Where DiagnosTear Technologies, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| CSE:DTR · Home listing · This page | CSE | Canada | CAD |
| Tradegate:X8F | Tradegate | Germany | EUR |
| Cboe Canada:DTR | Cboe Canada | Canada | CAD |
| Frankfurt:X8F | Frankfurt | Germany | EUR |
| Hamburg:X8F | Hamburg | Germany | EUR |
Log in to ask 6ix AI your own questions about DiagnosTear Technologies, Inc.